Joy Cote

Joy Cote is a Principal Scientist at Prelude Therapeutics, having progressed through roles including Senior Research Scientist and Research Scientist in Biochemistry since March 2021. Prior to this, Joy served as a Postdoctoral Associate at Fox Chase Cancer Center from January 2018 to March 2021, working under Dr. Andrews. Joy's academic journey includes earning a Ph.D. in Chemistry from Wesleyan University, where significant research was conducted on E. coli HepI dynamics and mechanism under Professor Erika Taylor's supervision from August 2012 to January 2018. Joy holds a Bachelor of Science in Chemistry from the University of Mount Saint Vincent, awarded in 2012.